Tudor-Eliade Ciuleanu

PubHawk tracks social media discussions for 2 articles by authors named Tudor-Eliade Ciuleanu.

Mentions

83

Peak: 19 in Oct 2022

across 2 tracked articles

Extended reach

351,944

potential audience

Total likes

224

Video views

22,209

Mentions per month

Jun 2022 – Feb 2025

Where it's discussed

X / Twitter57 posts
News10 articles
Blogs6 articles
Reddit5 posts
YouTube3 videos
Facebook2 posts

Tracked by PubHawk

Most discussed articles

Feb 2023

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

Julie R Brahmer, Jong-Seok Lee, Tudor-Eliade Ciuleanu, et al.

62 mentions

X 42
News 8
Blogs 6
YouTube 2
+2 more

View analytics →

J Immunother Cancer Feb 2024

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.

David P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, et al.

21 mentions

X 15
Reddit 3
News 2
YouTube 1

View analytics →

From PubMed

All publications

Searching PubMed…